Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
about
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouseSpinal cord injury causes chronic liver pathology in rats.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Lactosylceramide Mediates the Expression of Adhesion Molecules in TNF-α and IFNγ-stimulated Primary Cultured Astrocytes.Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosisGlycosphingolipid functionsImmunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology.Sialylation of lactosyl lipids in membrane microdomains by T. cruzi trans-sialidase.Lactosylceramide-Induced Phosphorylation Signaling to Group IVA Phospholipase A2 via Reactive Oxygen Species in Tumor Necrosis Factor-α-Treated Cells.Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells.Lactosylceramide-accumulation in lipid-rafts mediate aberrant-autophagy, inflammation and apoptosis in cigarette smoke induced emphysema.The Role of Astrocytes in Multiple Sclerosis.Inhibitory Effect of Methotrexate on Rheumatoid Arthritis Inflammation and Comprehensive Metabolomics Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry (UPLC-Q/TOF-MS)
P2860
Q33594241-3B74F185-ED04-4D55-AF7E-033739B79636Q34983871-1D5A992C-D612-43FB-AE51-8DB3040F8DB5Q35324757-96BECD00-891D-40CD-991C-69C1EBBAA45DQ35569335-CB002675-489E-41A5-B85E-6D5A8EBAC0DEQ35818695-0E9F7E3D-9823-402E-92BF-F9E123FA2C45Q37873655-0E4C35B8-4288-4C2A-B3C5-50A8E01468DAQ37974938-E2BAD5C4-23A6-4671-A3B3-E642CAD57E51Q38147080-943D3238-33F8-4AE8-9574-F64E6371F918Q38303580-BC6B7618-1941-4E1C-92FB-D37BB3625E77Q38706010-47E60B68-0148-4FB9-9F6E-3F985101015EQ39071592-12969306-F2B9-4D31-894D-11A1B0989EDCQ45998689-3BA63CAF-022F-4EE0-98ED-6C9E44EB3303Q51662730-D6B71947-1498-41FA-859F-52782CB1F69AQ52668332-6C58907D-5B9B-46BA-9711-36C5EBAE50B2Q59138385-7346571F-855D-4234-8DB0-2B7B2B727625
P2860
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
@en
type
label
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
@en
prefLabel
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
@en
P2093
P2860
P1476
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.
@en
P2093
Avtar K Singh
Inderjit Singh
Je-Seong Won
P2860
P304
P356
10.1111/J.1471-4159.2007.04822.X
P407
P478
103 Suppl 1
P577
2007-11-01T00:00:00Z